Literature DB >> 21703534

NOD so fast: NLRX1 puts the brake on inflammation.

Kislay Parvatiyar1, Genhong Cheng.   

Abstract

In this issue of Immunity, Allen et al. (2011) and Xia et al. (2011) provide in vivo and biochemical evidence that NLRX1, a member of the nucleotide binding domain and leucine-rich-repeat-containing protein family, functions as a negative regulator of RIG-I and Toll-like receptors.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Year:  2011        PMID： 21703534      PMCID： PMC4061909          DOI： 10.1016/j.immuni.2011.06.006

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  10 in total

Review 1.  Signaling to NF-kappaB.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

Review 2.  Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.

Authors:  Michael Karin; Toby Lawrence; Victor Nizet
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

Review 3.  Pathogen recognition by the innate immune system.

Authors:  Himanshu Kumar; Taro Kawai; Shizuo Akira
Journal:  Int Rev Immunol       Date:  2011-02       Impact factor: 5.311

4.  NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK.

Authors:  Xiaojun Xia; Jun Cui; Helen Y Wang; Liang Zhu; Satoko Matsueda; Qinfu Wang; Xiaoang Yang; Jun Hong; Zhou Songyang; Zhijian J Chen; Rong-Fu Wang
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

5.  NLRX1/NOD5 deficiency does not affect MAVS signalling.

Authors:  M Rebsamen; J Vazquez; A Tardivel; G Guarda; J Curran; J Tschopp
Journal:  Cell Death Differ       Date:  2011-05-27       Impact factor: 15.828

6.  NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways.

Authors:  Irving C Allen; Chris B Moore; Monika Schneider; Yu Lei; Beckley K Davis; Margaret A Scull; Denis Gris; Kelly E Roney; Albert G Zimmermann; John B Bowzard; Priya Ranjan; Kathryn M Monroe; Raymond J Pickles; Suryaprakash Sambhara; Jenny P Y Ting
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

7.  NLRX1 is a regulator of mitochondrial antiviral immunity.

Authors:  Chris B Moore; Daniel T Bergstralh; Joseph A Duncan; Yu Lei; Thomas E Morrison; Albert G Zimmermann; Mary A Accavitti-Loper; Victoria J Madden; Lijun Sun; Zhengmao Ye; John D Lich; Mark T Heise; Zhijian Chen; Jenny P-Y Ting
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

8.  Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].

Authors:  Chuan-Jin Wu; Dietrich B Conze; Tao Li; Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Nat Cell Biol       Date:  2006-03-19       Impact factor: 28.824

9.  Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3.

Authors:  Wenwen Zeng; Ming Xu; Siqi Liu; Lijun Sun; Zhijian J Chen
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

10.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

Authors:  Chee-Kwee Ea; Li Deng; Zong-Ping Xia; Gabriel Pineda; Zhijian J Chen
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970
  10 in total
  8 in total

1.  Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus Monkeys.

Authors:  Dan H Barouch; Khader Ghneim; William J Bosche; Yuan Li; Brian Berkemeier; Michael Hull; Sanghamitra Bhattacharyya; Mark Cameron; Jinyan Liu; Kaitlin Smith; Erica Borducchi; Crystal Cabral; Lauren Peter; Amanda Brinkman; Mayuri Shetty; Hualin Li; Courtney Gittens; Chantelle Baker; Wendeline Wagner; Mark G Lewis; Arnaud Colantonio; Hyung-Joo Kang; Wenjun Li; Jeffrey D Lifson; Michael Piatak; Rafick-Pierre Sekaly
Journal:  Cell       Date:  2016-04-13       Impact factor: 41.582

Review 2.  Alarmins, inflammasomes and immunity.

Authors:  Najwane Saïd-Sadier; David M Ojcius
Journal:  Biomed J       Date:  2012 Nov-Dec       Impact factor: 4.910

Review 3.  Mitochondrial Regulation of Inflammasome Activation in Chronic Obstructive Pulmonary Disease.

Authors:  Chang Min Yoon; Milang Nam; Yeon-Mok Oh; Charles S Dela Cruz; Min-Jong Kang
Journal:  J Innate Immun       Date:  2015-11-05       Impact factor: 7.349

4.  NLRX1 modulates differentially NLRP3 inflammasome activation and NF-κB signaling during Fusobacterium nucleatum infection.

Authors:  Shu-Chen Hung; Pei-Rong Huang; Cássio Luiz Coutinho Almeida-da-Silva; Kalina R Atanasova; Ozlem Yilmaz; David M Ojcius
Journal:  Microbes Infect       Date:  2017-10-09       Impact factor: 2.700

Review 5.  NLR in eXile: Emerging roles of NLRX1 in immunity and human disease.

Authors:  Robert J Pickering; Lee M Booty
Journal:  Immunology       Date:  2020-12-28       Impact factor: 7.397

6.  Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2.

Authors:  Chia-Lin Chen; Jeffrey Y Huang; Chun-Hsiang Wang; Stanley M Tahara; Lin Zhou; Yasuteru Kondo; Joel Schechter; Lishan Su; Michael M C Lai; Takaji Wakita; François-Loïc Cosset; Jae U Jung; Keigo Machida
Journal:  Nat Commun       Date:  2017-01-09       Impact factor: 14.919

Review 7.  Heat Shock Proteins and Inflammasomes.

Authors:  Pierre Martine; Cédric Rébé
Journal:  Int J Mol Sci       Date:  2019-09-12       Impact factor: 5.923

Review 8.  Intracellular Antiviral Immunity.

Authors:  Maria Bottermann; Leo C James
Journal:  Adv Virus Res       Date:  2018-02-16       Impact factor: 9.937
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.